ODYSSEY OUTCOMES Trial Design Praluent® (alirocumab)
Learn more
This website contains promotional content and is intended for Healthcare Professionals based in the United Kingdom only. Some content is only relevant to HCPs practising in Great Britain (England, Scotland, Wales). This website is optimised for desktop use, and some features may perform differently on mobile devices.
Trurapi®▼ (insulin aspart 100 units/mL)
MAT-XU-2305061 (v2.0) Date of preparation: February 2024